HR 3391
118th Congress
House
Health
Banking and financial institutions regulation
Cancer
Child health
Civil actions and liability
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government trust funds
Health programs administration and funding
Medical research
National Institutes of Health (NIH)
Research administration and funding
Securities
Securities and Exchange Commission (SEC)
Gabriella Miller Kids First Research Act 2.0
Introduced: May 16, 2023
See on congress.gov
Everywhere this bill has been
26 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 4, 2025
Became Public Law No: 118-228.
Jan 4, 2025
Signed by President.
Dec 27, 2024
Presented to President.
Dec 23, 2024
Message on Senate action sent to the House.
Dec 20, 2024
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.
Dec 20, 2024
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
Dec 20, 2024
Passed Senate without amendment by Voice Vote. (consideration: CR S7297-7298)
Mar 8, 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 6, 2024
Received in the Senate.
Mar 5, 2024
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Mar 5, 2024
Motion to reconsider laid on the table Agreed to without objection.
Mar 5, 2024
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 384 - 4 (Roll no. 60). (text: CR H792)
Mar 5, 2024
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 384 - 4 (Roll no. 60). (text: CR H792)
Mar 5, 2024
Considered as unfinished business. (consideration: CR H805-806)
Mar 5, 2024
DEBATE - The House proceeded with forty minutes of debate on H.R. 3391.
Mar 5, 2024
Considered under suspension of the rules. (consideration: CR H792-793)
Mar 5, 2024
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Aug 25, 2023
Placed on the Union Calendar, Calendar No. 131.
Aug 25, 2023
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-165.
Jul 19, 2023
Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.
Jul 19, 2023
Committee Consideration and Mark-up Session Held.
Jul 13, 2023
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 27 - 0 .
Jul 13, 2023
Subcommittee Consideration and Mark-up Session Held.
May 19, 2023
Referred to the Subcommittee on Health.
May 16, 2023
Referred to the House Committee on Energy and Commerce.
May 16, 2023
Introduced in House
Votes taken on this bill
1
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Mar 5, 2024 | House · vote #60 | On Motion to Suspend the Rules and Pass, as Amended | Passed | 384–4 | See who voted → |
Plain-English summary
Gabriella Miller Kids First Research Act 2.0
This act reauthorizes through FY2028 a pediatric disease research initiative within the National Institutes of Health (NIH) and requires the NIH to coordinate pediatric research activities to avoid duplicative efforts. Additionally, the Department of Health and Human Services must report to Congress about research funded through the initiative.
What's happening now
Became Public Law No: 118-228.
Committees of jurisdiction
3